Literature DB >> 27401314

Electronic health records-Applications for the allergist/immunologist: All that glitters is not gold.

Lawrence D Frenkel1.   

Abstract

A review of existing literature on electronic health records (EHR) demonstrates the lack of a comprehensive analysis of the current status of, and impediments for, physicians, including allergists/immunologists, to adopting a fully functioning system. For physicians to logically embrace the use of EHRs, a comprehensive but straightforward presentation of this complex subject would be helpful. In fact, although there is some evaluative information regarding data derived from EHRs about asthma epidemiology and practice guidelines as well as recording adverse allergic reactions, it is impossible to find one scholarly article that evaluated the use of fully functional EHRs from the perspective of an allergist or immunologist. This analysis presents a review of the background and goals of EHRs and describes the major problems that delayed their widespread acceptance. Necessary solutions to the problems are presented in this article. The potential benefits of better EHRs could foster widespread acceptance and use of these systems.

Entities:  

Mesh:

Year:  2016        PMID: 27401314     DOI: 10.2500/aap.2016.37.3959

Source DB:  PubMed          Journal:  Allergy Asthma Proc        ISSN: 1088-5412            Impact factor:   2.587


  3 in total

1.  Science, lifestyle, and human health: Challenging trilogy for the allergist/immunologist.

Authors:  Joseph A Bellanti; Russell A Settipane
Journal:  Allergy Asthma Proc       Date:  2016-07       Impact factor: 2.587

2.  Relievers, controllers, and inhaler technique: A physician-patient challenge.

Authors:  Joseph A Bellanti; Russell A Settipane
Journal:  Allergy Asthma Proc       Date:  2016-09       Impact factor: 2.587

Review 3.  Scribes, EHRs, and Workflow Efficiencies in Allergy Practices.

Authors:  Annette F Carlisle; Saul M Greenbaum; Mike S Tankersley
Journal:  Curr Allergy Asthma Rep       Date:  2020-07-09       Impact factor: 4.806

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.